Akt/mTOR Counteract the Antitumor Activities of Cixutumumab, an Anti-Insulin-Like Growth Factor I Receptor Monoclonal Antibody
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-11-0235
Full Text
Open PDFAbstract
Available in full text
Date
October 6, 2011
Authors
Publisher
American Association for Cancer Research (AACR)